ELS-tíðindi - október 2002 - Einkaleyfastofan
ELS-tíðindi - október 2002 - Einkaleyfastofan
ELS-tíðindi - október 2002 - Einkaleyfastofan
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
58 <strong>ELS</strong> <strong>tíðindi</strong> 10/02<br />
(21) 6571<br />
(22) 27.9.<strong>2002</strong><br />
(41) 27.9.<strong>2002</strong><br />
(51) A61K 33/24; A61K 31/337; A61K<br />
31/7068; A61P 35/00; A61K 45/06<br />
(54) Samsett lyfjameðferð.<br />
(71) AnorMed Inc., No. 200-20353, 64th<br />
Avenue, Langley, British Columbia,<br />
Canada V2Y 1N5, Kanada.<br />
(72) Mark Peart Smith; Trevor Charles<br />
Stephens; Macclesfield, Cheshire,<br />
Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 18.5.2000, GB, 0011903.2<br />
(85) 27.9.<strong>2002</strong><br />
(86) 10.5.2001, PCT/GB01/02060<br />
(21) 6572<br />
(22) 27.9.<strong>2002</strong><br />
(41) 27.9.<strong>2002</strong><br />
(51) E04F 15/04<br />
(54) Gólfefni, sem samanstendur af<br />
plötulaga gólfeiningum, sem eru<br />
skeyttar saman af tengieiningum.<br />
(71) Pergo (Europe) AB, Strandridaregatan<br />
8, S-231 25 Trelleborg, Svíþjóð.<br />
(72) Jörgen Pålsson, Landskrona,<br />
Svíþjóð.<br />
(74) Björn Árnason, Árni Björnsson,<br />
Pósthólf 1552, 121 Reykjavík.<br />
(30) 31.3.2000, SE, 0001149-4<br />
(85) 27.9.<strong>2002</strong><br />
(86) 14.2.2001, PCT/SE01/00294<br />
(21) 6573<br />
(22) 30.9.<strong>2002</strong><br />
(41) 30.9.<strong>2002</strong><br />
(51) F03D 9/00; F03B 13/18<br />
(54) Vind- og ölduknúið orkuver.<br />
(71) Henrik Frans Christensen,<br />
Guldbergsgade 9, 4. tv, DK-2200<br />
Copenhagen N, Danmörku.<br />
(72) Henrik Frans Christensen, Copenhagen<br />
N, Danmörku.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 3.4.2000, DK, PA 2000 00550<br />
(85) 30.9.<strong>2002</strong><br />
(86) 3.4.2001, PCT/DK01/00222<br />
(21) 6574<br />
(22) 30.9.<strong>2002</strong><br />
(41) 30.9.<strong>2002</strong><br />
(51) C07D 401/14; C07D 405/14; C07D<br />
409/14; C07D 211/68; A61K 31/4523;<br />
A61P 25/04; A61P 25/00<br />
(54) Kínólinýl-píperidín-4-ýlíden-metýlbensamíðafleiður<br />
til að meðhöndla<br />
sársauka.<br />
(71) AstraZeneca AB, S-151 85 Södertälje,<br />
Svíþjóð.<br />
(72) William Brown; Christopher Walpole;<br />
Zhongyong Wei; St. Laurent,<br />
Quebec, Kanada.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 4.4.2000, SE, 0001208-8<br />
(85) 30.9.<strong>2002</strong><br />
(86) 30.3.2001, PCT/SE01/00708<br />
(21) 6575<br />
(22) 30.9.<strong>2002</strong><br />
(41) 30.9.<strong>2002</strong><br />
(51) C07D 401/06; C07D 405/06; C07D<br />
409/06; C07D 211/68; A61K 31/4523;<br />
A61P 25/04; A61K 25/00<br />
(54) Hýdroxýfenýl-píperidín-4-ýlídenmetýl-bensamíðafleiður<br />
til að<br />
meðhöndla sársauka.<br />
(71) AstraZeneca AB, S-151 85 Södertälje,<br />
Svíþjóð.<br />
(72) William Brown; Christopher Walpole;<br />
Zhongyong Wei; St. Laurent, Quebec,<br />
Kanada.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 4.4.2000, SE, 0001207-0<br />
(85) 30.9.<strong>2002</strong><br />
(86) 30.3.2001, PCT/SE01/00707<br />
Veitt<br />
einkaleyfi<br />
<strong>Einkaleyfastofan</strong> hefur í<br />
samræmi við 20. gr. laga<br />
nr. 17/1991 með síðari<br />
breytingum, veitt eftirtalin<br />
einkaleyfi. Andmæli gegn<br />
einkaleyfunum skulu hafa<br />
borist <strong>ELS</strong> innan 9 mánaða<br />
frá birtingu þessarar<br />
auglýsingu, sbr. 21. gr.<br />
laganna.<br />
(51) G01G 19/00; G01G 19/24; G01G<br />
19/38; G01G 19/39; G01G 19/387;<br />
G01G 19/393<br />
(11) 1758<br />
(45) 1.2.2001<br />
(45) 20.9.<strong>2002</strong><br />
(48) 18.10.<strong>2002</strong><br />
(41) 6.9.1999<br />
(21) 4682<br />
(22) 5.3.1998<br />
(54) Aðferð til nákvæms og sjálfvirks<br />
þyngdarsamvals úr raðflæði stykkja.<br />
(73) Póls hf., Sindragötu 10, 400 Ísafirði,<br />
Íslandi.<br />
(72) Bjarni Guðmundsson, Ísafirði,<br />
Íslandi.<br />
(30) Enginn.<br />
(51) C07K 9/00; C07H 15/203; C07D<br />
487/04; C07D 401/04; A61K 31/02<br />
(11) 1822<br />
(45) 1.10.<strong>2002</strong><br />
(41) 18.9.1997<br />
(21) 4562<br />
(22) 18.9.1997<br />
(54) Glýkósamstæður, lyf sem innihalda<br />
þær, og notkun glýkósamstæðnanna<br />
við framleiðslu lyfja.<br />
(73) Bayer Aktiengesellschaft, D-<br />
51368 Leverkusen, Þýskalandi.<br />
(72) Hans-Georg Lerchen, Leverkusen;<br />
Karsten von dem Bruch, Leverkusen;<br />
Uwe Petersen, Leverkusen; Jörg<br />
Baumgarten, Wuppertal; Norbert<br />
Piel, Erkrath; Horst-Peter Antonicek,<br />
Bergisch Gladbach; Walter Weichel,<br />
Odenthal; Michael Sperzel,<br />
Wuppertal; Klaus Dieter Bremm,<br />
Recklinghausen; Þýskalandi.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 4.4.1995, DE, 195 12 484.7<br />
(85) 18.9.1997<br />
(86) 22.3.1996, PCT/EP96/01279